Evaluating the Impact of Cardiopulmonary Bypass Priming Fluids on Bleeding After Pediatric Cardiac Surgery: A

K Siemens1, P Donnelly1, B J Hunt2

  • 1PICU Evelina London Children's Hospital, St Thomas' Hospital, London, United Kingdom.

Insights

Cardiopulmonary bypass (CPB) priming fluids did not significantly affect pediatric perioperative bleeding. This systematic review found no evidence that different solutions impact blood loss in children undergoing cardiac surgery.

Area of Science:

  • Pediatric Cardiac Surgery
  • Coagulopathy Research
  • Cardiovascular Anesthesia

Background:

  • Cardiopulmonary bypass (CPB) is associated with coagulopathy in pediatric patients.
  • Understanding the impact of CPB priming fluids on bleeding is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the effect of different cardiopulmonary bypass priming fluids on perioperative bleeding in pediatric cardiac surgery.
  • To systematically review randomized controlled trials (RCTs) investigating CPB priming solutions.

Main Methods:

  • Systematic review and meta-analysis of 20 RCTs published between 1980 and 2020.
  • Included patients under 18 years without hematologic disorders.
  • Primary outcome: postoperative bleeding; secondary outcomes: transfusion, mortality, safety.

Main Results:

  • No significant difference in 24-hour blood loss was found between different CPB priming solutions (mean difference -0.13; p=0.92).
  • Fresh frozen plasma (FFP), albumin, and artificial colloids were frequently assessed interventions.
  • Heterogeneity in study design, population, and interventions limited definitive conclusions.

Conclusions:

  • Current evidence does not support a significant effect of various CPB priming solutions on 24-hour blood loss in pediatric cardiac surgery.
  • Limitations include heterogeneity across studies, impacting the strength of conclusions.
  • Further research with standardized methodologies is warranted.
Abstract